MeiraGTx & Eli Lilly Partner for Gene Therapy Eye Diseases

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded10 Nov 2025

Publisherfeeds.acast.com ↗

Handlerec:2198871

Show notes

MeiraGTx and Eli Lilly form a partnership to develop gene therapies for eye diseases, with Eli Lilly gaining exclusive global rights to MeiraGTxs AAV-AIPL1 program targeting LCA four. The collaboration also grants Eli Lilly access to MeiraGTxs advanced gene therapy technologies for eye applications. MeiraGTx receives a $75 million upfront payment and potential additional payments, while Eli Lilly expands its presence in ophthalmology.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.